“associate(s)”

“BeiGene AUS”

“BeiGene Beijing”

“BeiGene Biologics”

“BeiGene Guangzhou”

“BeiGene Guangzhou

Manufacturing”

“BeiGene HK”

“BeiGene Pharmaceutical

(Shanghai)”

“BeiGene Shanghai”

“BeiGene Suzhou”

DEFINITIONS

has the meaning ascribed to it under the Listing Rules

BeiGene AUS Pty Ltd., a company incorporated under the
laws of Australia on July 15, 2013 and a wholly owned
subsidiary of the Company

BeiGene (Beijing) Co., Ltd.* (百濟神州(北京)生物科技有限
公司), a company incorporated under the laws of the PRC on
January 24, 2011 and an indirectly wholly owned subsidiary
of the Company

BeiGene Biologics Co., Ltd.* (百濟神州生物藥業有限公司),
a company incorporated under the laws of the PRC on January
25, 2017 and indirectly held by the Company as to 95% of its
equity interests and by GET as to 5% of its equity interests

BeiGene (Guangzhou) Co., Ltd.* (百濟神州(廣州)生物科技有
限公司), a company incorporated under the laws of the PRC
on July 11, 2017 and an indirectly wholly owned subsidiary of
the Company

BeiGene Guangzhou Biologics Manufacturing Co., Ltd.* (廣
州百濟神州生物製藥有限公司),
incorporated
under the laws of the PRC on March 3, 2017 and a wholly
owned subsidiary of BeiGene Biologics

company

a

BeiGene (Hong Kong) Co., Limited, a company incorporated
under the laws of Hong Kong on November 22, 2010 and a
wholly owned subsidiary of the Company

formerly

BeiGene Pharmaceutical (Shanghai) Co., Ltd.* (百濟神州醫
藥信息諮詢(上海)有限公司),
as Baiji
Pharmaceutical (Shanghai) Co., Ltd. (百繼醫藥信息諮詢（上
海）有限公司) and “Celgene Pharmaceutical (Shanghai) Co.,
Ltd.*
company
incorporated under the laws of the PRC on December 15,
2009 and an indirectly wholly owned subsidiary of
the
Company

(新基醫藥信息諮詢(上海)有限公司)”,

known

a

BeiGene (Shanghai) Co., Ltd.* (百濟神州(上海)生物科技有
限公司), a company incorporated under the laws of the PRC
on September 11, 2015 and a wholly owned subsidiary of
BeiGene Biologics

BeiGene (Suzhou) Co., Ltd.* (百濟神州(蘇州)生物科技有限
公司), a company incorporated under the laws of the PRC on
April 9, 2015 and an indirectly wholly owned subsidiary of
the Company

— 24 —

